|Articles|October 14, 2019
Protein Aggregate Assessment of Ligand Binding Assay (LBA) Reagents using SEC-MALS
Author(s)Wyatt
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
2
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
3
Generative AI and Adaptive Trials Shape Future Biotech Development
4
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
5